CMPX 8-K 2026-09-22

Compass Therapeutics, Inc. (CMPX) 8-K dated 2026-09-22 — accession 0001171843-26-006162. This URL is the filing, not the CMPX hub.

Compass Therapeutics, Inc. (CMPX) is a biotechnology company listed on US.

Compass Therapeutics, Inc. filed a 8-K on 2026-09-22. Accession 0001171843-26-006162.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CMPX revenue for 2025-12-31 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CMPX currently screens at market cap $367.4M.

Not investment advice. The CMPX SEC hub lists recent forms. The stock page is the research view.